Supriya Lifescience Limited (BOM:543434)
India · Delayed Price · Currency is INR 863.35
+26.65 (3.19%)
At close: Jul 21, 2026
Supriya Lifescience Market Cap
Supriya Lifescience has a market cap or net worth of 67.62 billion as of July 22, 2026. Its market cap has increased by 20.36% in one year.
Market Cap
67.62B
Enterprise Value
66.89B
Revenue
8.28B
Ranking
n/a
PE Ratio
32.34
Stock Price
863.35
ChartMarket Cap Chart
Since December 28, 2021, Supriya Lifescience's market cap has increased from 31.46B to 67.62B, an increase of 114.97%. That is a compound annual growth rate of 18.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 22, 2026 | 67.62B | 11.80% |
| Dec 31, 2025 | 60.48B | 1.58% |
| Dec 31, 2024 | 59.54B | 135.04% |
| Dec 29, 2023 | 25.33B | 33.91% |
| Dec 30, 2022 | 18.92B | -51.41% |
| Dec 31, 2021 | 38.93B | 23.76% |
| Dec 28, 2021 | 31.46B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CORONA Remedies | 125.14B |
| Viyash Scientific | 115.53B |
| Procter & Gamble Health | 113.67B |
| Sanofi India | 78.16B |
| FDC Limited | 68.13B |
| Bliss GVS Pharma | 51.90B |
| Unichem Laboratories | 41.89B |
| Novartis India | 41.30B |